Archive: Clinical Trial Candidates

Is Giving Patients the “Right to Try” the Right Move?

Author: tdower
Posted: June 6th, 2018

While the Right-to-Try Act may appear to have a patient-centric focus, it will likely increase risk for seriously ill patients and weaken the FDA’s power to protect patients taking experimental medication.

FDA Releases New Clinical Trial Diversity Data

Posted: July 19th, 2017

Patient diversity in clinical trials is improving slowly – here’s one solution that might help speed things up.

Bolstering Diversity in Clinical Trials

Posted: August 10th, 2016

Clinical trials have a diversity problem, and it could be having a negative impact on their ability to secure FDA approval. Here’s what you need to know.

Are You Keeping Your Clinical Trial Candidates in the Dark?

Posted: March 10th, 2016

Clinical trials are still struggling to recruit and retain participants, which results not only in staggering costs for trial sponsors, but also prevents patients from gaining access to new treatments and medications – and the solution could be as simple as candidate education.